Dolasetron and Nalbuphine: Interaction Details
- Dolasetron
- Anzemet
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Dolasetron and Nalbuphine interaction:
Nalbuphine
We don't have a drug information page for Nalbuphine yet. Have a question about Nalbuphine? Ask a pharmacist, free →
What Happens When You Take Dolasetron With Nalbuphine
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Cases of serotonin syndrome have been reported when pentazocine is taken together with agents. These include , and norepinephrine reuptake , , , 5-HT3 receptor , drugs that interfere with serotonin , and other agents acting on the serotonergic system.
Patients should be monitored closely, particularly when treatment is started and when doses are changed. The syndrome presents with altered mental status, , , hyperreflexia, muscle rigidity, nausea, vomiting, and diarrhea; if it is suspected, nalbuphine should be discontinued.1
The Dolasetron and Nalbuphine Interaction, Explained
Dolasetron (Anzemet) prevents nausea and vomiting, and nalbuphine is an pain medicine. Both can affect , a natural brain chemical. Taken together, they could in theory raise serotonin too much, a rare problem called . This risk is based on theory, not on many confirmed cases with this exact pair.
Warning signs include confusion, a racing heart, muscle stiffness, twitching, diarrhea, and vomiting. Please don't stop or change either medicine on your own. Tell your pharmacist or doctor about both, and speak up right away if you notice these symptoms. Your care team can watch you closely, especially when a dose is new or changed.
Interaction: may increase the risk of with dolasetron (5-HT3 receptor ) and nalbuphine ( -antagonist). Labeling for nalbuphine and related opioids lists 5-HT3 antagonists among serotonergic agents of concern.
- Evidence: theoretical; onset unspecified. Severity on file: major.
- Presentation: mental status changes, , , hyperreflexia, rigidity, nausea, vomiting, diarrhea.
- Management: if is necessary, monitor for serotonin syndrome, especially at initiation and dose changes. Discontinue nalbuphine if suspected.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Dolasetron and Nalbuphine Interact
The likely mechanism
How to Manage the Dolasetron and Nalbuphine Interaction
If you need both medicines, your care team can manage this with careful watching rather than avoiding the combination automatically.
- Your team may monitor you more closely, especially when either medicine is started or the dose is adjusted.
- Keep taking both as prescribed unless your prescriber tells you otherwise.
- Know the warning signs: confusion, fast heartbeat, low blood pressure, muscle stiffness or twitching, vomiting, and diarrhea.
- If these appear, contact your doctor or pharmacist right away. If is suspected, nalbuphine is stopped by your prescriber.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Dolasetron or Nalbuphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Dolasetron and Nalbuphine: Common Questions
How serious is the Dolasetron and Nalbuphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Dolasetron and Nalbuphine interaction managed?
If you need both medicines, your care team can manage this with careful watching rather than avoiding the combination automatically. Your team may monitor you more closely, especially when either medicine is started or the dose is adjusted. Keep taking both as prescribed unless your prescriber tells you otherwise. Know the warning signs: confusion, fast heartbeat, low blood pressure, muscle stiffn… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Dolasetron and Nalbuphine Interaction
Ask in your own words about taking Dolasetron and Nalbuphine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: NUBAIN(R) intramuscular, subcutaneous, intravenous injection, nalbuphine HCl intramuscular, subcutaneous, intravenous injection. Par Pharmaceutical (per FDA), Chestnut Ridge, NY, 2016.
Other Serious Interactions of Dolasetron and Nalbuphine
Also serious with Dolasetron
- DronedaroneContraindicated
- LevoketoconazoleContraindicated
- PhenelzineContraindicated
- PimozideContraindicated
Also serious with Nalbuphine
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Dolasetron
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- LithiumMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- + 165 more
With Nalbuphine
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- BeerMajor
- Gamma-hydroxybutyrate (GHB)Major
- L-TryptophanMajor
- AshwagandhaModerate
- + 92 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.